Aspercreme Lidocaine XL
NDC 62168-0585, Lidocaine, patch, from Lead Chemical Co., Ltd..
- Product NDC
- 62168-0585
- Status
- Listed
- Labeler
- Lead Chemical Co., Ltd.
- Dosage form
- PATCH
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62168-0585 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE411.4 mg/1
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62168-0585-2 | 62168058502 | 240 POUCH in 1 CARTON (62168-0585-2) / 1 PATCH in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62168-0585 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62168-0585 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62168-0585. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.